Loading organizations...
Loading organizations...
HeartLab is a technology company.
HeartLab develops a cloud-based platform for cardiology imaging, streamlining the entire cardiac imaging workflow. This core product integrates capabilities from acquisition to comprehensive echocardiography data analysis, enhancing efficiency and collaboration among clinicians. The system provides medical professionals with accessible, integrated solutions for managing diagnostic images.
Founded in 2018 in Auckland, New Zealand, HeartLab was conceived by Will Hewitt. He developed the foundational insight as a first-year applied mathematics student at the Auckland Bioengineering Institute, recognizing the opportunity to modernize complex cardiology diagnostics through innovative, accessible software solutions.
HeartLab's platform is utilized by cardiology centers and medical professionals, predominantly in North America and Japan. The company's vision is to advance cardiac care globally by continually developing intelligent, user-friendly imaging solutions that improve diagnostic accuracy and patient outcomes, thereby elevating cardiovascular health standards.
HeartLab has raised $2.0M across 1 funding round.
HeartLab has raised $2.0M in total across 1 funding round.
HeartLab is a New Zealand-based healthtech startup founded in 2018 that provides a cloud-based cardiology imaging platform designed to replace legacy on-premise PACS (Picture Archiving and Communication Systems) products. It offers an end-to-end solution for echocardiograms—ultrasound tests used to examine heart structure and function—using AI to analyze images, streamline workflows, generate patient reports, and enable remote access from connected devices, serving cardiologists, clinicians, and healthcare teams diagnosing cardiovascular disease.[1][2][3][4]
The platform targets hospitals, clinics, and cardiology practices worldwide, solving key pain points like manual review of time-consuming scans, inefficient data sharing, and limited remote collaboration. HeartLab has raised under $5 million across two funding rounds (including $3.5 million from Founders Fund), grown its team to double digits, and expanded from New Zealand to clinics in Australia and the US, where heart disease is the leading cause of death, demonstrating strong early momentum amid rising demand for AI-driven cardiac care.[1][2]
HeartLab was co-founded in 2018 by Will Hewitt, who was just 18 years old at the time, alongside a team addressing the manual, time-intensive process of reviewing echocardiograms for heart disease diagnosis—one of the world's most preventable causes of death. Based in Auckland, New Zealand, Hewitt's vision emerged from recognizing how AI could accelerate insights from these scans, reducing clinician workload and improving accuracy.[2][4]
Early traction came through New Zealand's healthtech ecosystem, including Callaghan Innovation support for incubation, funding, interns, and market validation. Pivotal moments include raising $3.5 million from Founders Fund, team expansion, and international launches in Australia and the US after initial NZ testing, navigating challenges as a regulated medical device.[2]
HeartLab stands out in cardiology imaging through these key strengths:
HeartLab rides the AI-healthtech wave in cardiovascular care, where heart disease drives massive need—especially in the US—and cloud/AI tools address clinician shortages, rising imaging volumes, and post-pandemic remote work demands. Its timing aligns with global regulatory shifts enabling SaaS medical devices and exploding demand for efficient diagnostics amid aging populations and preventable disease burdens.[2][3]
Market forces like healthtech funding ecosystems (e.g., Callaghan Innovation, Founders Fund) and cross-border expansion favor HeartLab, positioning it to influence cardiology by standardizing cloud workflows, boosting AI adoption in imaging, and enabling faster interventions that could scale to reduce global heart disease mortality.[1][2]
HeartLab's youth belies its poised trajectory: expect accelerated US penetration as the largest heart disease market, potential Series A funding to fuel AI enhancements, and partnerships with major EHR systems for broader integration. Trends like multimodal AI (combining imaging with genomics) and telecardiology will amplify its edge, evolving it from niche echocardiogram tool to comprehensive cardiac platform.
With founder Will Hewitt's bold start at 18, HeartLab exemplifies how AI can humanize high-stakes healthcare, delivering the end-to-end efficiency that cardiologists need to fight the cardiovascular crisis head-on.[2][4]
HeartLab has raised $2.0M in total across 1 funding round.
HeartLab's investors include Correlation Ventures, DST Global, Felicis Ventures, ff Venture Capital, Founders Fund, FTX Ventures, Paradigm, Balaji Srinivasan, Justin Mateen, Dylan Field, Icehouse Ventures, Outset Ventures.
HeartLab has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in September 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2021 | $2.0M Seed | Correlation Ventures, DST Global, Felicis Ventures, ff Venture Capital, Founders Fund, FTX Ventures, Paradigm, Balaji Srinivasan, Justin Mateen, Dylan Field, Icehouse Ventures, Outset Ventures |